I'm curious as to your take on the Xcede patch and I went so far as to read some of your other posts- you seem to possibly have some medical training.
If they can get funding for this and some medically oriented investors take an equity position, the stock could skyrocket because it would be perceived as a validation of the product, which is targeting a big market.
I'm hoping for an explosion. I think a lot of us are!!!
Looking pretty good in a bad market.
I said I'd add if insiders buy, so I did again- - even if it may be getting toppy.
Last market sell-off we had I rated MITK a C+, based on how it held up- but today, so far it's a B.
Needs to break close over $3.40 and refuse to go lower in order to turn more bullish. Earnings have been good. Nice growth, last 5 Q's. Back off the non recurring expense and it's turning quite profitable.
Mobile Photo Pay was not a complete dud but the most recent attempt at getting a better suite of products involved buying an existing, growing business with a track record to judge it's products by.
If it works, look out.
Recent article about online identity verification:
Black is beautiful. EBITDA must be fixed. New CEO makes a lot of progress but we need more for a turnaround.
Adjusted EBITDA from continuing operations in the second quarter of 2015 was negative $2.4 million compared to a negative $1.6 million in the first quarter of 2015. The sequential decline in adjusted EBITDA resulted largely from an increase in operating expenses during the quarter. The increase in operating expenses resulted from an increase in professional fees such as legal, audit, tax and shareholder-related expenses related to a number of complex nonrecurring transactions taking place in the quarter such as the divestiture of the Airline Media Network business and the conversion of our convertible preferred stock into common shares.
I just want to mention biotech AXGN did perform well from where I had it at $2.50. It's my 2nd biggest micro cap after ARIS, then ITI, followed closely by DYSL. They had some good top line last Q but what sent it to over $5 was the equity funding that also brought some super expertise to their BOD.
So this makes me think DYSL, with it's miniscule float may go crazy to the upside if they too can get some funding and bring some validation to the strategy to take it through to FDA.
If you like low priced turnaround plays, read last transcript of RMGN- it sounds ripe to me and I took a tiny position.
In the last CC they downplayed the near term opportunities for connected vehicle revenues but this is a nice chunk to add to the top line growth. Margins continue to grow. Top line continues to grow. Ag products seem to be ready for a slow but steady, high margin ramp. Insider buying. Connected vehicles are a tailwind. Any more contracts like this and we could see a lot more legs to this breakout.
On August 7, ARI Network Services, Inc. (NASDAQ: ARIS) announced today that its Endeavor dealer website platform for marine dealers now integrates with Moreboats.com, a pay-per-lead and pay-per-call marine inventory marketplace.
Nice news. From last CC:
Edward M. Woo - Ascendiant Capital
Yeah, thank you for as well as congratulations on a very great quarter. I did have a question, you mentioned about some of the movements you are doing in international. Should we expect more news over the next year on your focus and expansion in that area and do you see opportunities not just in Europe but also in Asia or emerging markets?
Roy W. Olivier - President and CEO
That’s a great question. I mean we do continue to see -- we do expect to continue to see some improved new bookings performance and ultimately revenue from our European operation. That said every year as we prioritize where we are investing for growth in the future we typically are investing in projects that will drive growth in the domestic market and we don’t make a tremendous amount of investments in Europe. So I don’t expect Europe to suddenly start to double or triple in size but I do expect continued stronger new bookings and ultimately stronger revenue.
The recent funding means the company and it's products have been vetted with DD and this highly qualified expert in the field wants a stake in the future.So how high does it go for now and, if you still want to add, should you wait for a pullback? That is the question many may be asking.Nice to own such a stock.
O.K. Sorry. There's been quite a few filings to buy.
27-Aug-2015 2:05 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 25 Filed by: DALY KEVIN
27-Aug-2015 1:58 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 20 Filed by: THOMAS TOM
26-Aug-2015 8:30 AM ET Market Wire Iteris to Present at the 4th Annual Liolios Gateway Conference on September 10, 2015
25-Aug-2015 5:45 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 24 Filed by: MINER GREG
24-Aug-2015 7:36 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 20 Filed by: DALY KEVIN
24-Aug-2015 6:52 PM ET EDGAR SEC Filings Form 4/A ITERIS, INC. For: Aug 18 Filed by: DALY KEVIN
20-Aug-2015 7:13 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 18 Filed by: DALY KEVIN
20-Aug-2015 4:12 PM ET EDGAR SEC Filings Form 4 ITERIS, INC. For: Aug 18 Filed by: MINER GREG
Here's another theory. Around the last two weeks of July they get the Conservis deal and they set up a booth at the an Ag conference where they got 30 Ag businesses setting up meetings, 30 from one conference.
A week or so later insiders start buying.
From CC transcript:
Of significant note we had a fantastic show in the InfoAg at St. Louis in the fourth week of July with over 30 meetings with potential ClearAg partners and customers of global scale many of whom actively sought us out at the meeting.
Several trends are indicative of the changes we've made over the past quarter. The first is the introduction of the new component line which I mentioned earlier. This new class of products significantly enhances the ability to integrate ClearAg with third party software systems such as SMIS, as illustrated by our recent Conservis customer announcement. The second is incorporation of an element of customer specific engineering as a component of major ClearAg relationships. This maybe reflected as modeling-as-a-service or other purpose designed auxiliary capabilities that address unique interests of the customer. We recently announced our first ClearAg modeling-as-a-service contract with the Minnesota Wheat Growers Association.
Wow! I just added at $3.95 and I'm still up 72%. Nice run up on the good news about funding.